17288-47-0 Usage
Uses
Used in Pharmaceutical Industry:
(1H-pyrrolo[3,2-b]pyridin-2-yl)methanol is used as a therapeutic agent for the treatment of various diseases, such as cancer, inflammation, and neurodegenerative disorders. Its ability to inhibit the Src family of kinases contributes to its potential effectiveness in these applications.
Used in Cancer Therapy:
(1H-pyrrolo[3,2-b]pyridin-2-yl)methanol is used as a targeted cancer therapy agent due to its anti-proliferative and anti-migratory properties in cancer cells, which can help in controlling tumor growth and progression.
Used in Inflammatory Disease Treatment:
(1H-pyrrolo[3,2-b]pyridin-2-yl)methanol is used as an anti-inflammatory agent, leveraging its capacity to modulate inflammatory responses, which can be beneficial in managing inflammatory conditions.
Used in Neurodegenerative Disorder Research:
(1H-pyrrolo[3,2-b]pyridin-2-yl)methanol is used as a research tool to study and potentially treat neurodegenerative disorders, given its ability to regulate neuronal function and its potential to influence cellular signaling pathways related to these conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 17288-47-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,2,8 and 8 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 17288-47:
(7*1)+(6*7)+(5*2)+(4*8)+(3*8)+(2*4)+(1*7)=130
130 % 10 = 0
So 17288-47-0 is a valid CAS Registry Number.
17288-47-0Relevant academic research and scientific papers
COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF
-
Paragraph 0076-0077; 00149-00150, (2021/10/30)
The present invention relates to novel Collagen 1 translation inhibitors, composition and methods of preparation thereof, and uses thereof for treating Fibrosis including lung, liver, kidney, cardiac and dermal fibrosis, IPF, wound healing, scarring and Gingival fibromatosis, Systemic Sclerosis, and alcoholic and non-alcoholic steatohepatitis (NASH).
